In general, in cancer metabolism, indoleamine-2,3-dioxygenase (IDO)1, IDO2, and tryptophan-2,3-dioxygenase (TDO2) are activated in the first step of tryptophan degradation [25,26]. This evidence concerns the gene IDO2 and cancer.